Novel cinchona alkaloid derivatives as potential antimalarial agents through receptor-inhibitor interaction fingerprint and biosynthesis design

Rosmalena, Vivitri D. Prasasty, Muhammad Hanafi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Malaria parasites have become the major health threat in increasing resistance toward common antimalarial drugs and become prime factors causing the strength of the disease. The objective of this study was investigating novel cinchona alkaloid derivatives (CADs) as potential antimalarial agents through molecular docking, pharmacopore modeling and biosynthesis design. Protein structure and cinchona alkaloid derivative structures were taken and performed for molecular interaction studies, pharmacophore modeling and mapping the binding modes of receptor-inhibitors which may increase the possibility of success rate in finding potential antimalarial candidates. Here, we report the greatest prospective inhibitor of Plasmodium falciparum (Pf falcipain-2, PDB ID code 2 ghu ) falcipain-2 is cinchonidine salicylate (-9.1 kcal/mol) through molecular docking approach. This compound exhibited distortion free of Lipinski's rule. Hence, cinchonidine salicylate showed the most potential compound as antimalarial inhibitor over other cinchona alkaloid derivatives. Eventually, we construct biosynthesis pathways by using iron oxide nanoparticle (IONP) that could act as a coated nanoparticle to the natural bioactives to acquire optimum yield of the product by making coated nanoparticle with CADs which are powerful biosynthesis application in green environment of aqueous solution.

Original languageEnglish
Pages (from-to)2643-2650
Number of pages8
JournalOriental Journal of Chemistry
Volume34
Issue number5
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Antimalaria
  • Biosynthesis
  • Cinchona alkaloid derivatives
  • Molecular docking

Fingerprint

Dive into the research topics of 'Novel cinchona alkaloid derivatives as potential antimalarial agents through receptor-inhibitor interaction fingerprint and biosynthesis design'. Together they form a unique fingerprint.

Cite this